Atoratin Tablet 20 mg (Atorvastatin Calcium Trihydrate)
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Alpha Pharmaceutical Co., Ltd.
MFDS item code 201904538 · Approved 2019.07.03
This product's status changed to Expired on 2024.07.03. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Improvement of hyperlipidemia, improvement of pediatric familial hypercholesterolemia, and prevention of cardiovascular disease
This medication is primarily used to reduce the risk of cardiovascular disease. It decreases the risk of myocardial infarction and stroke in adults aged 55 years or older, or those who smoke, have hypertension, low HDL cholesterol, or a family history of cardiovascular disease. It also lowers the risk of vascular procedures and angina. In patients with type 2 diabetes who have risk factors for heart disease, it helps in the reduction of myocardial infarction and stroke risks. Additionally, in patients with existing coronary artery disease, it reduces the risks of myocardial infarction, stroke, vascular procedures, as well as hospitalizations due to congestive heart failure and angina. For patients with hyperlipidemia, it effectively lowers total cholesterol, LDL cholesterol, apo-B proteins, and triglyceride levels while increasing HDL cholesterol. It also acts as an adjunct to dietary therapy for pediatric patients with familial hypercholesterolemia to help alleviate blood lipid levels. This medication is used to reduce the risk of cardiovascular disease and improve hyperlipidemia.
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. Atorvastatin may be taken at any time of day, with or without food. Hyperlipidemia: The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses of this medicine should be individualized according to patient characteristics, taking treatment goals and response into consideration. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or adjusting the dose, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended to use LDL cholesterol levels when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol levels should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia: The dose of this medicine is 10 ~ 80 mg once daily. It should be used in combination with other lipid-lowering therapies (e.g., LDL apheresis), or when such therapies are not available. Patients with renal impairment: Renal disease does not affect the plasma concentration of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dose adjustment is required. Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult population.
10 ~ 17 years: The recommended initial dose is 10 mg of this medicine per day, and the recommended maximum dose is 20 mg per day (there are no clinical data on doses higher than 20 mg of this medicine in pediatric patients). The dose should be adjusted appropriately for each patient according to the recommended treatment goals. The dose should be adjusted at intervals of 4 weeks or longer.
This medication may cause muscle abnormalities; therefore, if severe muscle pain or weakness occurs, the medication should be immediately discontinued and a doctor should be consulted. If there is a significant increase in muscle enzyme levels or suspicion of myopathy, the use of this medication should be stopped. It should not be used in patients with liver function issues or liver disease, and if liver function tests show abnormalities, medical personnel should be notified immediately. Women who are pregnant, may become pregnant, or are breastfeeding should not take this medication. It is not recommended for children, especially those under 10 years of age. Those with allergic reactions to this medication or hypersensitivity to its components should avoid use. Patients with a history of alcohol addiction or liver disease should use this medication cautiously and undergo regular assessments as directed by their doctor. Elderly patients or those with impaired kidney function are also at increased risk of myopathy and should use caution. There may be interactions when taken with other medications; therefore, inform your doctor about any medications you are currently taking. Special caution is advised when using this medication together with certain antibiotics, antifungals, HIV treatments, specific heart medications, grapefruit juice, etc. If symptoms such as muscle pain, fatigue, fever, etc. arise during treatment, inform medical personnel immediately and undergo testing. Additionally, if serious skin reactions occur such as rash, itching, hives, or in severe cases, Stevens-Johnson syndrome, discontinue use. This medication should be kept out of reach of children and should be stored in its original container. There is no specific antidote for overdose; appropriate treatment should be provided based on symptoms, with regular blood tests and liver function tests being necessary.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from air and moisture, and it is safe to keep it at room temperature between 1°C and 30°C.
White, round, film-coated tablet
30 tablets - 30 tablets/bottle, 300 tablets - 300 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Atorvastatin Calcium Hydrate 21.7mg
Tablet · Prescription medication
Alpha Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.7mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 43.4mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Viatris Korea Co., Ltd.

Atorvastatin Calcium Trihydrate 10.85mg
Tablet · Prescription medication
Kyungdong Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Shinil Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 21.69mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.

Atorvastatin Calcium Trihydrate 10.845mg
Tablet · Prescription medication
Daewon Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.